Design of RESILIENCE: A phase 3 trial comparing capecitabine in combination with sorafenIb or placebo for treatment of locally advanced or metastatIc HER2-negative breast cancer Meeting Abstract
| Authors: | Baselga, J.; Costa, F.; Gomez, H.; Hudis, C.; Rapoport, B.; Roche, H.; Schwartzberg, L. S.; Petrenciuc, O.; Shan, M.; Gradishar, W. J. |
| Abstract Title: | Design of RESILIENCE: A phase 3 trial comparing capecitabine in combination with sorafenIb or placebo for treatment of locally advanced or metastatIc HER2-negative breast cancer |
| Meeting Title: | 8th European Breast Cancer Conference (EBCC 8) |
| Journal Title: | European Journal of Cancer |
| Volume: | 48 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2012 Mar 21-24 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-03-01 |
| Start Page: | S117 |
| Language: | English |
| ACCESSION: | WOS:000302804600266 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(12)70324-6 |
| Notes: | --- - Meeting Abstract: 257 - 8th European Breast Cancer Conference (EBCC) - MAR 21-24, 2012 - Vienna, AUSTRIA - "Source: Wos" |
